Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ITIH5 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA545830
Description
Peptide sequence: ASEDQDIEFQ MQIPAAAFIT NFTMLIGDKV YQGEITEREK KSGDRVKEKR Sequence homology: Cow: 79%; Dog: 79%; Guinea Pig: 79%; Human: 100%; Mouse: 86%; Rabbit: 92%; Rat: 93%.
This gene encodes a heavy chain component of one of the inter-alpha-trypsin inhibitor (ITI) family members. ITI proteins are involved in extracellular matrix stabilization and in the prevention of tumor metastasis. They are also structurally related plasma serine protease inhibitors and are composed of a light chain and varying numbers of heavy chains. This family member is thought to function as a tumor suppressor in breast and thyroid cancers. Alternative splicing results in multiple transcript variants.
Specifications
ITIH5 | |
Polyclonal | |
Unconjugated | |
ITIH5 | |
4631408O11Rik; 5430408M01Rik; DKFZp686F0145; E130106B02; inter-alpha (globulin) inhibitor H5; inter-alpha trypsin inhibitor heavy chain precursor 5; inter-alpha-inhibitor heavy chain 5; inter-alpha-trypsin inhibitor heavy chain 5; inter-alpha-trypsin inhibitor heavy chain family member 5; inter-alpha-trypsin inhibitor heavy chain family, member 5; inter-alpha-trypsin inhibitor heavy chain H5; ITI heavy chain H5; ITIH5; ITI-HC5; KIAA1953; MGC10848; PP14776; UNQ311/PRO354 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
80760 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
Q86UX2 | |
ITIH5 | |
Synthetic peptide directed towards the N-terminal of human ITIH5 (aa 77-126). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction